{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:36:36Z","timestamp":1794105396483,"version":"4.8.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.amjmed.2016.03.038","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T01:17:30Z","timestamp":1464484650000},"page":"1000.e7-1000.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Emerging Concepts in Glaucoma and Review of the Literature"],"prefix":"10.1016","volume":"129","author":[{"given":"Antonio","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-5010","authenticated-orcid":false,"given":"Maria Ida","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"De Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fusconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"de Vincentiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2016.03.038_bib1","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.amjmed.2016.03.038_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9394(99)80084-1","article-title":"Anti-Ro\/SS-a positivity and heat shock protein antibodies in patients with normal-pressure glaucoma","volume":"125","author":"Wax","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0031-1273355","article-title":"Autoimmunity and glaucoma","volume":"228","author":"Grus","year":"2011","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.amjmed.2016.03.038_bib4","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1167\/iovs.12-9781","article-title":"The pathogenesis of glaucoma in the interplay with the immune system","volume":"54","author":"Rieck","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2016.03.038_bib6","first-page":"324","article-title":"The Bjerrum scotoma","volume":"62","author":"Harrington","year":"1964","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.amjmed.2016.03.038_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0042-6989(03)00038-5","article-title":"Filling-in of retinal scotomas","volume":"43","author":"Zur","year":"2003","journal-title":"Vision Res"},{"issue":"9","key":"10.1016\/j.amjmed.2016.03.038_bib8","first-page":"1229","article-title":"Chronic open-angle glaucoma","volume":"51","author":"Adatia","year":"2005","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.amjmed.2016.03.038_bib9","first-page":"1","article-title":"Nongranulomatous Inflammation: Uveitis, Endophthalmitis, Panophthalmitis, and Sequelae","volume":"vol. 3","author":"Read","year":"2004"},{"key":"10.1016\/j.amjmed.2016.03.038_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.exer.2010.08.016","article-title":"The case for autoimmunity in glaucoma","volume":"93","author":"Wax","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib11","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.amjmed.2016.03.038_bib12","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM199111143252005","article-title":"Undertreatment of glaucoma among black Americans","volume":"325","author":"Javitt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2016.03.038_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00439-001-0645-7","article-title":"A\u00a0major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene","volume":"110","author":"Aung","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.amjmed.2016.03.038_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/pmic.200300375","article-title":"Analysis of complex autoantibody repertoires by surface-enhanced laser desorption\/ionization-time of flight mass spectrometry","volume":"3","author":"Grus","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.amjmed.2016.03.038_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2010.09.005","article-title":"A\u00a0biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma","volume":"93","author":"Burgoyne","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1620\/tjem.197.125","article-title":"Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients","volume":"197","author":"Maruyama","year":"2002","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.amjmed.2016.03.038_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.neuro.051508.135728","article-title":"Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy","volume":"35","author":"Nickells","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.preteyeres.2005.04.004","article-title":"Glaucoma: thinking in new ways\u2014a r\u00f4le for autonomous axonal self-destruction and other compartmentalised processes?","volume":"24","author":"Whitmore","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2006.02.061","article-title":"Retinal ganglion cell line apoptosis induced by hydrostatic pressure","volume":"1086","author":"Agar","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.brainresbull.2003.07.007","article-title":"The molecular biology of retinal ganglion cell death: caveats and controversies","volume":"62","author":"Nickells","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.amjmed.2016.03.038_bib24","first-page":"341","article-title":"p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-D-aspartate","volume":"8","author":"Li","year":"2002","journal-title":"Mol Vis"},{"key":"10.1016\/j.amjmed.2016.03.038_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3129\/can j ophthalmol.i07-036","article-title":"From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma","volume":"42","author":"Nickells","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200767050-00006","article-title":"Pharmacological neuroprotection for glaucoma","volume":"67","author":"Chidlow","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.amjmed.2016.03.038_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ohc.2005.04.002","article-title":"Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies","volume":"18","author":"Kuehn","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.amjmed.2016.03.038_bib28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mcn.2004.05.002","article-title":"Invulnerability of retinal ganglion cells to NMDA excitotoxicity","volume":"26","author":"Ullian","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0074-7742(09)85028-9","article-title":"Identification of novel pharmacological targets to minimize excitotoxic retinal damage","volume":"85","author":"Russo","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib30","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1046\/j.1460-9568.2003.02657.x","article-title":"Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins","volume":"17","author":"Aronica","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib31","first-page":"1940","article-title":"Concurrent downregulation of a glutamate transporter and receptor in glaucoma","volume":"41","author":"Naskar","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/bbrc.2001.5427","article-title":"Heat shock proteins: endogenous modulators of apoptotic cell death","volume":"286","author":"Garrido","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.amjmed.2016.03.038_bib34","first-page":"2884","article-title":"A\u00a0model of experimental autoimmune glaucoma in rats elicited by immunization with heat shock protein27","volume":"43","author":"Wax","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib35","first-page":"4048","article-title":"Stress proteins and immunostimulatory signaling through toll-like receptors in glaucoma","volume":"50","author":"Luo","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib36","first-page":"1","article-title":"Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept","volume":"296","author":"Oldstone","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0079-6123(08)01128-X","article-title":"TNF-alpha signaling in glaucomatous neurodegeneration","volume":"173","author":"Tezel","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor necrosis factor-\u03b1: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head","volume":"32","author":"Yuan","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.amjmed.2016.03.038_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archopht.118.4.511","article-title":"Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes","volume":"118","author":"Tezel","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib40","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1167\/iovs.05-0685","article-title":"Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States","volume":"47","author":"Grus","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.imlet.2005.03.017","article-title":"Autoimmunity against neurofilament protein and its possible association with HLA-DRB1*1502 allele in glaucoma","volume":"100","author":"Yano","year":"2005","journal-title":"Immunol Lett"},{"issue":"suppl","key":"10.1016\/j.amjmed.2016.03.038_bib42","first-page":"342","article-title":"Antiphospholipid antibodies in patients with normal tension glaucoma","volume":"40","author":"Shokoohi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2249.2001.01578.x","article-title":"Antiphosphatidylserine antibodies are elevated in normal tension glaucoma","volume":"125","author":"Kremmer","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib44","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bjo.2003.040832","article-title":"Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies","volume":"88","author":"Kremmer","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib45","first-page":"144","article-title":"Hearing disorders with glaucoma","volume":"231","author":"Kremmer","year":"2014","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.amjmed.2016.03.038_bib46","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1167\/iovs.05-0208","article-title":"Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model\u00a0of glaucoma","volume":"46","author":"Tezel","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1167\/iovs.08-2717","article-title":"The role of glia, mitochondria, and the immune system in glaucoma","volume":"50","author":"Tezel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00405-004-0877-y","article-title":"Antiphospholipid antibodies in patients with sensorineural hearing loss","volume":"262","author":"Bachor","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archopht.1981.03930010635009","article-title":"Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage","volume":"99","author":"Quigley","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5005\/jp-journals-10008-1021","article-title":"Glaucoma: the neuro-ophthalmologic differential diagnosis","volume":"2","author":"Moster","year":"2008","journal-title":"J\u00a0Curr Glaucoma Pract"},{"key":"10.1016\/j.amjmed.2016.03.038_bib51","first-page":"58","article-title":"18th Annual Glaucoma Report. Optic neuropathies: glaucomatous vs. non-glaucomatous","volume":"149","author":"Hutchinson","year":"2012","journal-title":"Rev Optom"},{"key":"10.1016\/j.amjmed.2016.03.038_bib52","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ophtha.2010.09.002","article-title":"Optic disc evaluation in optic neuropathies: the optic disc assessment project","volume":"118","author":"O'Neill","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.amjmed.2016.03.038_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of\u00a0normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.12703\/P6-102","article-title":"Novel therapies for open-angle glaucoma","volume":"6","author":"Wentz","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.amjmed.2016.03.038_bib55","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.survophthal.2008.08.008","article-title":"How does lowering of intraocular pressure protect the optic nerve?","volume":"53","author":"Mackenzie","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib56","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/S0042-6989(02)00188-8","article-title":"Effects of anti-glaucoma medications on ganglion cell survival: the DBA\/2J mouse model","volume":"42","author":"Schuettauf","year":"2002","journal-title":"Vision Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib57","first-page":"191","article-title":"Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 Study","volume":"119","author":"Pfeiffer","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0079-6123(08)01131-X","article-title":"Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection","volume":"173","author":"Nucci","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.amjmed.2016.03.038_bib59","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1016\/S0039-6257(01)00200-4","article-title":"Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey","volume":"45","author":"Hare","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib60","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjmed.2016.03.038_bib61","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1167\/iovs.12-9483m","article-title":"Advances in glaucoma treatment and management: outflow drugs","volume":"53","author":"Kaufman","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.amjmed.2016.03.038_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.preteyeres.2013.02.003","article-title":"Does autoimmunity play a part in the pathogenesis of glaucoma?","volume":"36","author":"Bell","year":"2013","journal-title":"Prog Retin Eye Res"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316304053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316304053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:09:20Z","timestamp":1757581760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934316304053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002934316304053"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.03.038","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Concepts in Glaucoma and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}